Catalyst Wire Dossier Catalyst Wire Dossier

Fuganlin Oral Liquid

· Guangzhou Yipinhong Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Fuganlin Oral Liquid, covering 2017-05-22 to 2017-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection

See pricing